 - The participant is at increased baseline risk for osteosarcoma, such as those with Pagets disease of bone or unexplained elevations of alkaline phosphatase, hereditary disorders predisposing to osteosarcoma, or with a prior history of external beam or implant radiation therapy involving the skeleton. 